Cereno Insights Series: CS1 -PAH Clinical Trial Design with Sörensen, Dahlöf & Adamson

02 Feb 2023


A conversation between Cereno’s CEO, Sten R. Sörensen and CMO, Björn Dahlöf, joined by Philip B. Adamson, CMO, Heart Failure Division, Divisional Vice President at Abbott, USA - who met at the ESC Congress in Barcelona, in August 2022.

Watch here >